Mesenchymal Stem Cells for Perianal Crohn’s Disease
Perianal fistulizing Crohn’s disease (PFCD) is associated with significant morbidity and might negatively impact the quality of life of CD patients. In the last two decades, the management of PFCD has evolved in terms of the multidisciplinary approach involving gastroenterologists and colo...
Main Authors: | Michele Carvello, Amy Lightner, Takayuki Yamamoto, Paulo Gustavo Kotze, Antonino Spinelli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/7/764 |
Similar Items
-
Current Overview on the Use of Mesenchymal Stem Cells for Perianal Fistula Treatment in Patients with Crohn’s Disease
by: Marcin Włodarczyk, et al.
Published: (2021-10-01) -
Adenocarcinoma Arising from Perianal Fistulizing Crohn’s Disease
by: Rosario Fornaro, et al.
Published: (2018-08-01) -
Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn’s Disease
by: Deng F, et al.
Published: (2021-07-01) -
Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis
by: Fares Ayoub, et al.
Published: (2022-04-01) -
Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn’s disease: a pilot study
by: Juan Wei, et al.
Published: (2023-10-01)